ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE

ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE was reported 154 times

These side effects are most commonly reported by patients taking ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE:

# Side effect Count
0 ANTI FACTOR VIII ANTIBODY POSITIVE 37
1 DRUG INEFFECTIVE 26
2 HAEMORRHAGE 20
3 OFF LABEL USE 14
4 DEATH 8
5 FACTOR VIII INHIBITION 8
6 PULMONARY EMBOLISM 6
7 DEEP VEIN THROMBOSIS 5
8 DRUG EFFECT DECREASED 5
9 INHIBITING ANTIBODIES 5
10 CONDITION AGGRAVATED 4
11 HAEMATOMA 4
12 MUSCLE HAEMORRHAGE 4
13 PNEUMONIA 4
14 THERAPEUTIC RESPONSE DECREASED 4
15 ANTI FACTOR VIII ANTIBODY INCREASED 3
16 COGNITIVE DISORDER 3
17 COVID-19 3
18 EPILEPSY 3
19 MENINGITIS ASEPTIC 3
20 NO ADVERSE EVENT 3
21 SEPSIS 3
22 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
23 ABDOMINAL PAIN 2
24 ATELECTASIS 2
25 ATRIAL FIBRILLATION 2
26 BILIARY DILATATION 2
27 BRONCHIAL WALL THICKENING 2
28 CEREBROVASCULAR ACCIDENT 2
29 COAGULATION FACTOR VIII LEVEL ABNORMAL 2
30 COAGULATION FACTOR VIII LEVEL DECREASED 2
31 COVID-19 PNEUMONIA 2
32 DECREASED APPETITE 2
33 DELIRIUM 2
34 DISSEMINATED INTRAVASCULAR COAGULATION 2
35 EMBOLISM 2
36 FALL 2
37 GASTROINTESTINAL HAEMORRHAGE 2
38 GENERAL PHYSICAL HEALTH DETERIORATION 2
39 GINGIVAL BLEEDING 2
40 HIATUS HERNIA 2
41 INTENTIONAL PRODUCT USE ISSUE 2
42 INTRA-ABDOMINAL HAEMORRHAGE 2
43 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2
44 NAUSEA 2
45 NECROSIS 2
46 NEUTROPENIA 2
47 OXYGEN SATURATION DECREASED 2
48 PLEURAL EFFUSION 2
49 PRODUCT USE IN UNAPPROVED INDICATION 2
50 RENAL FAILURE 2
51 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2
52 THERAPY NON-RESPONDER 2
53 THROMBOTIC MICROANGIOPATHY 2
54 ACUTE RESPIRATORY FAILURE 1
55 ANGIOPATHY 1
56 ANTI FACTOR VIII ANTIBODY TEST 1
57 ANTIBODY TEST POSITIVE 1
58 BARRETT^S OESOPHAGUS 1
59 BLOOD LOSS ANAEMIA 1
60 BRONCHIAL HAEMORRHAGE 1
61 CARDIOGENIC SHOCK 1
62 CARDIOPULMONARY FAILURE 1
63 CELLULITIS 1
64 CHEMOTHERAPY 1
65 CHEST WALL HAEMATOMA 1
66 COAGULATION FACTOR VIII LEVEL INCREASED 1
67 COLITIS ISCHAEMIC 1
68 CONFUSIONAL STATE 1
69 CONTUSION 1
70 CORONARY ARTERY DISEASE 1
71 DEHYDRATION 1
72 DISCOMFORT 1
73 DRUG CLEARANCE INCREASED 1
74 DRUG EFFECT INCOMPLETE 1
75 DYSGEUSIA 1
76 DYSPNOEA 1
77 EATING DISORDER 1
78 EYELID PTOSIS 1
79 FACTOR VIII ACTIVITY DECREASED 1
80 FIBRIN D DIMER INCREASED 1
81 HAEMARTHROSIS 1
82 HAEMATOMA MUSCLE 1
83 HAEMATURIA 1
84 HAEMOPHILIA 1
85 HAEMOTHORAX 1
86 HOSPITALISATION 1
87 HYPERCOAGULATION 1
88 HYPOAESTHESIA 1
89 IMPERFORATE OESOPHAGUS 1
90 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
91 INFECTION 1
92 INHIBITING ANTIBODIES POSITIVE 1
93 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1
94 INTESTINAL ISCHAEMIA 1
95 KIDNEY INFECTION 1
96 LEUKOPENIA 1
97 LIP HAEMATOMA 1
98 MASS 1
99 MIXED DEMENTIA 1
100 MYOCARDIAL INFARCTION 1
101 NONINFECTIVE GINGIVITIS 1
102 NONSPECIFIC REACTION 1
103 OESOPHAGEAL HAEMORRHAGE 1
104 ORAL CONTUSION 1
105 ORAL DISCOMFORT 1
106 OSTEOMYELITIS 1
107 PETIT MAL EPILEPSY 1
108 PHARYNGEAL HAEMORRHAGE 1
109 PLEURISY 1
110 PNEUMONIA KLEBSIELLA 1
111 PNEUMONIA PSEUDOMONAL 1
112 POOR VENOUS ACCESS 1
113 POST PROCEDURAL CONTUSION 1
114 POSTOPERATIVE ILEUS 1
115 PRIAPISM 1
116 PRODUCT DISTRIBUTION ISSUE 1
117 PRODUCT USE ISSUE 1
118 PROTEUS TEST POSITIVE 1
119 PSEUDOMONAL SEPSIS 1
120 PULMONARY SEPSIS 1
121 RENAL IMPAIRMENT 1
122 RESPIRATORY DISORDER 1
123 RESPIRATORY TRACT INFECTION 1
124 RESPIRATORY TRACT INFLAMMATION 1
125 RETROPERITONEAL HAEMATOMA 1
126 SEIZURE 1
127 SKIN HAEMORRHAGE 1
128 SPEECH DISORDER 1
129 STAPHYLOCOCCAL BACTERAEMIA 1
130 STAPHYLOCOCCAL SEPSIS 1
131 SUBARACHNOID HAEMORRHAGE 1
132 SUBDURAL HAEMATOMA 1
133 THERAPEUTIC PRODUCT EFFECT DECREASED 1
134 THERAPEUTIC PRODUCT INEFFECTIVE 1
135 THERAPEUTIC RESPONSE INCREASED 1
136 THERAPY RESPONDER 1
137 THROMBOCYTOPENIA 1
138 TREATMENT FAILURE 1
139 TREMOR 1
140 UNDERDOSE 1
141 UNEVALUABLE EVENT 1
142 UPPER GASTROINTESTINAL HAEMORRHAGE 1
143 URETHRAL ABSCESS 1
144 URINARY TRACT INFECTION 1
145 UROSEPSIS 1
146 VESSEL PUNCTURE SITE HAEMATOMA 1
147 WOUND COMPLICATION 1